Retrodifferentiation Technology

Tristem's Technology

TriStem’s proven proprietary technology offers the potential to prepare large quantities of stem cells from the patient's own blood by the process of retrodifferentiation and, therefore, provides substantial benefits, both in terms of cost effectiveness and potential clinical outcomes to be gained from infusing higher concentrations of stem cells including more committed subsets. In addition, the technology provides a new source of stem cell supply which represents a quantum leap in yield when compared with current harvesting methods. Significantly, the procedure does not involve the need for a donor, nor does it require potentially uncomfortable, potentially hazzardous invasive surgical procedures.